E

    Electrocore LLC (ECOR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $9.49
    -0.14 (-1.40%)

    Market Cap: $86.78M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(18/33)
    Avg Surprise
    +0.92%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.27
    Range$-0.31 - $-0.23
    5 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.29-5.1%
    60d ago$-0.29-5.1%
    30d ago$-0.27+0.7%
    7d ago$-0.28-3.9%
    Current$-0.27
    Revenue Consensus
    $11M
    Range$11M - $11M
    5 analysts
    Dec 31, 2026
    EPS Consensus$-0.07
    Range$-0.17 - $0.07
    5 analysts
    Revenue Consensus
    $12M
    Range$12M - $13M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.07---
    Sep 26EST
    		-$-0.27---
    Jun 26
    		$-0.33$-0.41+19.51%Beat+25.0%
    Mar 26
    		$-0.59$-0.61+3.28%Beat-25.5%
    Dec 25
    		$-0.34$-0.39+13.38%Beat+15.0%
    Sep 25
    		$-0.40$-0.36-11.11%Miss-29.0%
    Jun 25
    		$-0.44$-0.32-37.50%Miss-15.8%
    Mar 25
    		$-0.47$-0.45-4.44%Miss+11.3%
    Dec 24
    		$-0.40$-0.34-17.65%Miss+34.4%
    Sep 24
    		$-0.31$-0.33+6.06%Beat+54.4%
    Jun 24
    		$-0.38$-0.43+11.63%Beat+62.7%
    Mar 24
    		$-0.53$-0.59+10.17%Beat+54.7%
    Dec 23
    		$-0.61$-0.61+0.00%Beat+50.0%
    Sep 23
    		$-0.68$-0.79+13.92%Beat+43.3%
    Jun 23
    		$-1.02$-0.93-9.68%Miss+15.0%
    Mar 23
    		$-1.17$-0.99-18.18%Miss+0.0%
    Dec 22
    		$-1.22$-1.12-8.93%Miss-16.2%
    Sep 22
    		$-1.20$-1.05-14.29%Miss-33.3%
    Jun 22
    		$-1.20$-1.05-14.29%Miss-0.8%
    Mar 22
    		$-1.17$-1.05-11.43%Miss+29.1%
    Dec 21
    		$-1.05$-1.02-2.94%Miss+50.0%
    Sep 21
    		$-0.90$-1.20+25.00%Beat+40.0%
    Jun 21
    		$-1.19$-1.72+30.81%Beat+39.0%
    Mar 21
    		$-1.65$-1.69+2.37%Beat+59.3%
    Dec 20
    		$-2.10$-1.56-34.62%Miss+51.7%
    Sep 20
    		$-1.50$-1.87+19.79%Beat+69.3%
    Jun 20
    		$-1.95$-2.95+33.90%Beat+66.1%
    Mar 20
    		$-4.05$-3.45-17.39%Miss+42.6%
    Dec 19
    		$-4.35$-4.35+0.00%Beat+45.3%
    Sep 19
    		$-4.89$-7.50+34.80%Beat+27.6%
    Jun 19
    		$-5.75$-7.12+19.24%Beat-82.5%
    Mar 19
    		$-7.05$-6.45-9.30%Miss-1780.0%
    Dec 18
    		$-7.95$-8.00+0.63%Beat-39850.0%
    Sep 18
    		$-6.75$-5.70-18.42%Miss-
    Jun 18
    		$-3.15$-3.75+16.00%Beat-
    Mar 18
    		$-0.38$0.00N/AMiss-
    Dec 17
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-5.72EV/EBITDA0.16x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-40.00%Operating Margin-29.30%
    ROE-478.70%ROIC-346.85%
    Financial Health
    Debt/Equity-2.43xInterest Coverage-15.79x
    Current Ratio1.21xQuick Ratio1.00x
    Trading Statistics
    Beta0.94Avg Volume105.39K
    52-Week High$10.9552-Week Low$4.41

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.01
    SMA 20$9.26
    SMA 50$7.85
    SMA 200$6.79
    EMA 10$9.70
    EMA 20$9.22
    EMA 50$8.37
    EMA 200$7.38

    MACD

    Line: 0.66Signal: 0.74Hist: -0.08

    ADX

    ADX: 34.2+DI: 22.2-DI: 12.9

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down20.0
    PSAR$10.64

    Bollinger Bands

    Upper Band$11.95
    Lower Band$6.58
    %B Position5802%(Upper)
    Band Width0.54

    RSI (14-Day)

    Neutral
    55.9

    Momentum Oscillators

    Stoch %K46.3
    Stoch %D61.1
    Williams %R-65.5
    ROC (10d)-7.4%
    Momentum-0.76
    CCI (20d)21.6
    MFI (14d)51.7

    Volatility Measures

    ATR (14d)$0.85(9.0%)
    StdDev (20d)1.34
    Hist Vol102.0%(High)

    Volume Flow

    VWAP$9.53
    OBV242.2K
    AD Line-2.1M
    CMF (20d)0.195

    Volume Metrics

    Avg Vol (20d)103.5K
    Vol Ratio0.9x
    VWMA (20d)$9.00

    Pivot Points

    R3$10.77
    R2$10.38
    R1$10.00
    Pivot Point$9.61
    S1$9.23
    S2$8.84
    S3$8.46

    Advanced Oscillators

    TSI26.77
    Ultimate Osc47.9
    KST483.89

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$9.45M$9.58M$9.24M$8.69M$7.38M$6.72M$7.05M$6.55M$6.14M$5.44M$5.19M$4.51M
    Cost of Revenue$1.27M$1.22M$1.07M$1.22M$939,000$1.01M$994,000$1.06M$838,000$888,000$1.10M$661,000
    Gross Profit$8.18M$8.36M$8.17M$7.47M$6.44M$5.71M$6.05M$5.49M$5.30M$4.55M$4.09M$3.85M
    Operating Expenses$10.95M$13.68M$11.11M$10.35M$9.95M$9.53M$9.12M$8.14M$7.89M$8.40M$8.05M$7.97M
    R&D$818,000$740,000$920,000$662,000$511,000$642,000$805,000$521,000$635,000$399,000$1.11M$1.25M
    SG&A$10.13M$12.94M$10.19M$9.69M$9.44M$8.89M$8.32M$7.62M$7.26M$8.01M$6.94M$6.72M
    Operating Income$-2,772,000$-5,316,000$-2,941,000$-2,884,000$-3,506,000$-3,822,000$-3,071,000$-2,651,000$-2,591,000$-3,849,000$-3,958,000$-4,126,000
    Interest Income$40,000$52,000$85,000$62,000$68,000$83,000$133,000$159,000$55,000$225,000$135,000$94,000
    Interest Expense$321,000$318,000$43,000$208,000$5,000$5,000$128,000$5,000$64,000$0$49,000$0
    Income Before Tax$-3,059,000$-5,592,000$-2,984,000$-3,405,000$-3,671,000$-3,903,000$-3,199,000$-2,497,000$-2,655,000$-3,628,000$-4,007,000$-4,032,000
    Income Tax Expense$0$-321,000$51,000$0$0$-48,000$29,000$0$0$-122,000$25,000$0
    Net Income$-3,059,000$-5,271,000$-3,035,000$-3,405,000$-3,671,000$-3,855,000$-3,228,000$-2,497,000$-2,655,000$-3,506,000$-4,032,000$-4,032,000
    EBITDA$-2,665,000$-5,198,000$-1,767,000$-2,972,000$-3,784,000$-3,578,000$-2,368,000$-2,423,000$-2,462,000$-3,651,000$-3,898,000$-3,819,000
    EBIT$-2,778,000$-5,326,000$-2,687,000$-3,259,000$-3,734,000$-3,981,000$-2,948,000$-2,651,000$-2,710,000$-3,853,000$-4,142,000$-4,126,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ECOR

    Government Contracts

    Gov Obligations (TTM)
    $67575
    Gov Obligations / Revenue
    0.2%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    N/A

    Top agency: Department of Defense at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    FA300225P0015Department of DefenseDepartment of the Air Force$67575Aug 25, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    electroCore CFO Joshua Lev sells $200,120 in company stock By Investing.com

    electroCore's CFO, Joshua Lev, sold 20,000 shares of company stock for approximately $200,120 after exercising an equal number of stock options. These sales occurred in late August 2026, with the stock having seen significant year-to-date and past-year returns. Following these transactions, Lev directly holds 84,889 shares, including RSUs.

    Investing.com South Africa•8/26/26•
    Somewhat-Bullish

    electroCore (NASDAQ: ECOR) CFO exercises options, sells 20K shares

    electroCore's CFO and Interim President, Joshua S. Lev, exercised stock options for 20,000 shares at $4.50 per share across August 21, 24, and 25, 2026. On the same dates, he sold all 20,000 acquired shares in open-market transactions at weighted-average prices ranging from $9.36 to $10.22. Following these transactions, Lev retains 2,889 shares of common stock and 82,000 shares issuable under previously granted RSUs, subject to future vesting conditions.

    Stock Titan•8/26/26•
    Neutral

    electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

    electroCore's Truvaga, a non-invasive vagus nerve stimulation (nVNS) wellness brand, has been recognized as the 2026 Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards. The award highlights Truvaga's innovative combination of patented technology, thoughtful design, and a personalized customer experience aimed at making nervous system wellness accessible for everyday use. Truvaga devices support relaxation, stress management, sleep quality, and focus through convenient two-minute sessions.

    GlobeNewswire•8/25/26•
    Bullish

    electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates

    electroCore, Inc. (ECOR) reported a Q1 loss of $0.59 per share, aligning with the Zacks Consensus Estimate, while exceeding revenue estimates with $9.58 million. The company has surpassed revenue expectations in three of the last four quarters and its shares have seen a significant 55.9% increase this year. Analysts currently rate ECOR as a Zacks Rank #3 (Hold), indicating expected performance in line with the market.

    Eastern Progress•8/22/26•
    Somewhat-Bullish

    electrocore director Thomas Errico buys $49,272 in company stock By Investing.com

    electroCore, Inc. director Thomas J. Errico recently acquired 5,000 shares of the company's common stock for $49,272, bringing his total beneficial ownership to 343,332 shares. This purchase occurred as the stock trades near its 52-week high after a 90% gain over the last year, and InvestingPro analysis suggests the stock is undervalued. The company also reported Q2 financial results showing progress towards profitability with a smaller-than-expected adjusted loss per share and a 28% increase in revenue.

    Investing.com Nigeria•8/18/26•
    Bullish

    Frequently Asked Questions About ECOR

    Does ECOR pay dividends?
    Electrocore LLC (ECOR) does not currently pay a regular dividend.
    What is ECOR's market cap?
    Electrocore LLC (ECOR) has a market capitalization of $86.78M with a current stock price of $9.49.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In